1211331-43-9

Usage

Uses

Used in Pharmaceutical Industry:
3-Bromo-2,5-difluoropyridine is used as a building block for the synthesis of various biologically active compounds. Its presence in the molecular structure can contribute to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
3-Bromo-2,5-difluoropyridine is used as an intermediate in the production of insecticides, herbicides, and fungicides. Its chemical properties make it a valuable component in the formulation of these agricultural chemicals, which are essential for pest and weed control.
Used in Organic Synthesis:
3-Bromo-2,5-difluoropyridine is a versatile reagent in organic synthesis, enabling the construction of complex molecules with potential applications in both therapeutic and agricultural fields. Its unique structure allows for the creation of a wide range of compounds with diverse functionalities.
Safety Precautions:
It is important to handle 3-Bromo-2,5-difluoropyridine with care, as it is toxic and may cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken to minimize exposure and ensure the safe handling of 3-broMo-2,5-difluoropyridine.

Upstream product

• 869557-43-7 3-bromo-5-fluoropyridin-2-amine 
• 21717-96-4 2-amino-5-fluoropyridine 

Relevant academic research and scientific papers

PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT 1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, and G, are defined herein.

OXAZEPINE DERIVATIVES HAVING TNAP INHIBITORY ACTIVITY

The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I) or a pharmacologically acceptable salt thereof.

SULFONAMIDE COMPOUNDS HAVING TNAP INHIBITORY ACTIVITY

The present invention relates to a compound or a pharmacologically acceptable salt thereof having excellent tissue non-specific alkaline phosphatase inhibitory activity. The present invention provides a compound represented by the formula (I) or a pharmacologically acceptable salt thereof.

PROCESS FOR PREPARING BENZOIC ACID ESTERS

There is provided a more industrially advantageous process for preparing novel pyridine derivatives expected to be used as medicines. A process for preparing 3-(6-hydroxy-1-methyl-1H-benzimidazol-2-yl)benzoic acid esters as intermediates with high quality

PYRIDINE DERIVATIVE

The present invention relates to a novel pyridine derivative or a pharmacologically acceptable ester thereof, or a pharmacologically acceptable salt of the derivative or ester, which has an excellent hypoglycemic effect or treats and/or prevents the onset

HETEROARYLOXYCARBOCYCLYL COMPOUNDS AS PDE10 INHIBITORS

Heteroaryloxycarbocyclyl compounds of formula (I), and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, obsessive -compulsive disorder, and the like. Formula (I)